Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids

[1]  J. Faber,et al.  Procoagulant State in Current and Former Anabolic Androgenic Steroid Abusers , 2018, Thrombosis and Haemostasis.

[2]  P. Hovind,et al.  Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma? , 2018, Journal of hypertension.

[3]  F. Dela,et al.  Insulin sensitivity in relation to fat distribution and plasma adipocytokines among abusers of anabolic androgenic steroids , 2017, Clinical endocrinology.

[4]  Michael T. Lu,et al.  Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use , 2017, Circulation.

[5]  T. Biering-Sørensen,et al.  Global Longitudinal Strain by Echocardiography Predicts Long-Term Risk of Cardiovascular Morbidity and Mortality in a Low-Risk General Population: The Copenhagen City Heart Study , 2017, Circulation. Cardiovascular imaging.

[6]  A. Juul,et al.  Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study , 2016, PloS one.

[7]  G. Limongelli,et al.  Anabolic-androgenic steroids and athlete's heart: When big is not beautiful....! , 2016, International journal of cardiology.

[8]  Hans Torp,et al.  Myocardial strain imaging: how useful is it in clinical decision making? , 2015, European heart journal.

[9]  L. Holmberg,et al.  Anabolic steroids and cardiovascular risk: A national population-based cohort study. , 2015, Drug and alcohol dependence.

[10]  L. Reggiani Bonetti,et al.  Pathological changes in anabolic androgenic steroid users. , 2015, Journal of forensic and legal medicine.

[11]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[12]  M. Borggrefe,et al.  Myocardial Scar Detected by Cardiovascular Magnetic Resonance in a Competitive Bodybuilder With Longstanding Abuse of Anabolic Steroids , 2014, Asian journal of sports medicine.

[13]  R. Wood,et al.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. , 2014, Endocrine reviews.

[14]  C. S. Andreassen,et al.  The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. , 2014, Annals of epidemiology.

[15]  K. George,et al.  Ventricular structure, function, and focal fibrosis in anabolic steroid users: a CMR study , 2014, European Journal of Applied Physiology.

[16]  G. Maurer,et al.  Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction , 2013, Circulation. Cardiovascular imaging.

[17]  F. Backx,et al.  Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes. , 2013, International journal of cardiology.

[18]  G. Thiene,et al.  Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. , 2012, Forensic science international.

[19]  K. George,et al.  Anabolic steroid use and longitudinal, radial, and circumferential cardiac motion. , 2012, Medicine and science in sports and exercise.

[20]  C. Kramer,et al.  Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. , 2012, JACC. Cardiovascular imaging.

[21]  M. Picard,et al.  Long-Term Anabolic-Androgenic Steroid Use Is Associated With Left Ventricular Dysfunction , 2010, Circulation. Heart failure.

[22]  Sandeep N. Gupta,et al.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.

[23]  J. Krieger,et al.  Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats. , 2007, American journal of physiology. Heart and circulatory physiology.

[24]  R. Casaburi,et al.  Testosterone dose-response relationships in healthy young men. , 2001, American journal of physiology. Endocrinology and metabolism.

[25]  W. Mckenna,et al.  Scaling cardiac structural data by body dimensions: a review of theory, practice, and problems. , 1999, International journal of sports medicine.

[26]  J. Gwathmey,et al.  Androgen receptors mediate hypertrophy in cardiac myocytes. , 1998, Circulation.

[27]  D. DuBois,et al.  A formula to estimate the approximate surface area if height and weight be known , 1989 .

[28]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[29]  W. Bartsch.  Interrelationships between sex hormone-binding globulin and testosterone, 5α-dihydrotestosterone and oestradiol- 7β in blood of normal men , 1980 .

[30]  Michael Jerosch-Herold,et al.  T1 Mapping: Basic Techniques and Clinical Applications. , 2016, JACC. Cardiovascular imaging.

[31]  Paul D. Allison,et al.  Handling Missing Data by Maximum Likelihood , 2012 .

[32]  E. F. Du Bois,et al.  A formula to estimate the approximate surface area if height and weight be known. 1916. , 1989, Nutrition.

[33]  W. Bartsch.  Interrelationships between sex hormone-binding globulin and testosterone, 5 alpha-dihydrotestosterone and oestradiol-17 beta in blood of normal men. , 1980, Maturitas.